KRAS and neoplasm: In preclinical mice models, Stk11/Kras mutant tumors produced abundant IL-6 and were associated with neutrophil accumulation and inflammatory cytokines with immunosuppressive properties in the tumor microenvironment, along with increased levels of T-cell exhaustion markers, compared with normal lungs (27).